BERLIN, July 16 (Reuters) - Thermo Fisher Scientific TMO.N said on Thursday it had decided to raise its bid for Qiagen QIA.DE to 43 euros ($49.06) per share to reflect the German genetic test maker's improved business prospects since the coronavirus pandemic.
Thermo Fisher's cash offer represents a 35% premium to Qiagen's closing price on March 2, the two companies said in a statement.
($1 = 0.8764 euros)
(Reporting by Caroline Copley Editing by Michelle Martin)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.